Zaigang Zhou

2.0k total citations
41 papers, 1.7k citations indexed

About

Zaigang Zhou is a scholar working on Biomedical Engineering, Oncology and Cancer Research. According to data from OpenAlex, Zaigang Zhou has authored 41 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Biomedical Engineering, 11 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Zaigang Zhou's work include Nanoplatforms for cancer theranostics (23 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Zaigang Zhou is often cited by papers focused on Nanoplatforms for cancer theranostics (23 papers), Cancer, Hypoxia, and Metabolism (11 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Zaigang Zhou collaborates with scholars based in China, United States and Czechia. Zaigang Zhou's co-authors include Jianliang Shen, Chunjuan Zheng, Jinhui Wu, Yiqiao Hu, Yu Liu, Xin Jiang, Jiashe Chen, Ahu Yuan, Baoli Zhang and Wei Xiong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and ACS Nano.

In The Last Decade

Zaigang Zhou

40 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zaigang Zhou China 25 985 367 361 312 273 41 1.7k
Yupeng Wang China 23 687 0.7× 431 1.2× 258 0.7× 233 0.7× 203 0.7× 98 1.7k
Xi Wang China 22 330 0.3× 447 1.2× 234 0.6× 251 0.8× 142 0.5× 110 1.6k
Kai Shi China 22 559 0.6× 800 2.2× 727 2.0× 211 0.7× 173 0.6× 65 2.4k
Conglian Yang China 22 789 0.8× 575 1.6× 475 1.3× 397 1.3× 253 0.9× 51 1.7k
Yiyi Zhang China 15 863 0.9× 378 1.0× 225 0.6× 270 0.9× 165 0.6× 41 1.4k
Yixian Zhou China 20 1.0k 1.0× 654 1.8× 526 1.5× 133 0.4× 109 0.4× 40 2.4k
Fangman Chen China 23 1.2k 1.2× 561 1.5× 587 1.6× 345 1.1× 137 0.5× 80 2.2k
Xiaoling Xu China 29 978 1.0× 783 2.1× 609 1.7× 287 0.9× 186 0.7× 77 2.4k
Boyi Niu China 16 835 0.8× 623 1.7× 482 1.3× 113 0.4× 104 0.4× 20 2.1k
Ting Wen China 17 701 0.7× 497 1.4× 273 0.8× 201 0.6× 112 0.4× 26 1.7k

Countries citing papers authored by Zaigang Zhou

Since Specialization
Citations

This map shows the geographic impact of Zaigang Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zaigang Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zaigang Zhou more than expected).

Fields of papers citing papers by Zaigang Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zaigang Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zaigang Zhou. The network helps show where Zaigang Zhou may publish in the future.

Co-authorship network of co-authors of Zaigang Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Zaigang Zhou. A scholar is included among the top collaborators of Zaigang Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zaigang Zhou. Zaigang Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Xin, Lijie Zhu, Rui Meng, et al.. (2025). Overcoming radiation-induced PD-L1 and COX-2 upregulation by nitric oxide gas nanogenerator to sensitize radiotherapy of lung cancer. Biomaterials. 321. 123335–123335. 4 indexed citations
2.
Zhou, Zaigang, Chunjuan Zheng, Haoxiang Wang, et al.. (2024). Mitochondrial metabolism blockade nanoadjuvant reversed immune-resistance microenvironment to sensitize albumin-bound paclitaxel-based chemo-immunotherapy. Acta Pharmaceutica Sinica B. 14(9). 4087–4101. 17 indexed citations
3.
Zhou, Zaigang, Cheng Li, Chao Li, et al.. (2024). Mitochondria‐Targeted Nanoadjuvants Induced Multi‐Functional Immune‐Microenvironment Remodeling to Sensitize Tumor Radio‐Immunotherapy. Advanced Science. 11(26). e2400297–e2400297. 28 indexed citations
4.
Zhou, Zaigang, Xin Jiang, Lei Yi, et al.. (2024). Mitochondria Energy Metabolism Depression as Novel Adjuvant to Sensitize Radiotherapy and Inhibit Radiation Induced‐Pulmonary Fibrosis. Advanced Science. 11(26). e2401394–e2401394. 23 indexed citations
5.
Zhou, Zaigang, Rui Hu, Mingyue Dong, et al.. (2023). Metabolic Intervention Liposome Boosted Lung Cancer Radio‐Immunotherapy via Hypoxia Amelioration and PD‐L1 Restraint. Advanced Science. 10(18). e2207608–e2207608. 54 indexed citations
6.
Zhou, Zaigang, Jiashe Chen, Yu Liu, et al.. (2022). Cascade two-stage tumor re-oxygenation and immune re-sensitization mediated by self-assembled albumin-sorafenib nanoparticles for enhanced photodynamic immunotherapy. Acta Pharmaceutica Sinica B. 12(11). 4204–4223. 51 indexed citations
7.
Zhou, Zaigang, Yu Liu, Xin Jiang, et al.. (2022). Metformin modified chitosan as a multi-functional adjuvant to enhance cisplatin-based tumor chemotherapy efficacy. International Journal of Biological Macromolecules. 224. 797–809. 82 indexed citations
8.
Zhou, Zaigang, et al.. (2022). Chitosan biguanide induced mitochondrial inhibition to amplify the efficacy of oxygen-sensitive tumor therapies. Carbohydrate Polymers. 295. 119878–119878. 43 indexed citations
9.
Liu, Yu, Zaigang Zhou, Wei Xiong, et al.. (2022). Tumor Selective Metabolic Reprogramming as a Prospective PD‐L1 Depression Strategy to Reactivate Immunotherapy. Advanced Materials. 34(41). e2206121–e2206121. 105 indexed citations
10.
Chen, Gang, Yuna Qian, Hang Zhang, et al.. (2021). Advances in cancer theranostics using organic-inorganic hybrid nanotechnology. Applied Materials Today. 23. 101003–101003. 41 indexed citations
11.
Chen, Jiashe, Zaigang Zhou, Chunjuan Zheng, et al.. (2021). Chitosan oligosaccharide regulates AMPK and STAT1 pathways synergistically to mediate PD-L1 expression for cancer chemoimmunotherapy. Carbohydrate Polymers. 277. 118869–118869. 46 indexed citations
12.
13.
Qi, Xiaoliang, Mengying Zhang, Ting Su, et al.. (2020). Biocompatible Hydrogels Based on Food Gums with Tunable Physicochemical Properties as Scaffolds for Cell Culture. Journal of Agricultural and Food Chemistry. 68(12). 3770–3778. 44 indexed citations
14.
Zhou, Zaigang, Baoli Zhang, Haoran Wang, et al.. (2018). Two-stage oxygen delivery for enhanced radiotherapy by perfluorocarbon nanoparticles. Theranostics. 8(18). 4898–4911. 109 indexed citations
15.
Jiang, Xing, Kaikai Wang, Zaigang Zhou, et al.. (2017). Erythrocyte membrane nanoparticles improve the intestinal absorption of paclitaxel. Biochemical and Biophysical Research Communications. 488(2). 322–328. 16 indexed citations
16.
Zhou, Zaigang, et al.. (2015). HZ08 Reverse P-Glycoprotein Mediated Multidrug Resistance In Vitro and In Vivo. PLoS ONE. 10(2). e0116886–e0116886. 11 indexed citations
17.
Zhou, Zaigang, Jianming Ruan, Zaigang Zhou, & Jianpeng Zou. (2007). Influence of Non-isothermal Melt Crystallization on the Thermal Behavior and Morphology of Poly-L-lactide. Acta Physico-Chimica Sinica. 23(5). 647–650. 5 indexed citations
18.
Du, Mingyuan, Xianlin Han, Zaigang Zhou, & Siwei Wu. (2007). Determination of Sudan I in hot chili powder by using an activated glassy carbon electrode. Food Chemistry. 105(2). 883–888. 77 indexed citations
19.
Zhou, Zaigang. (2004). Direct oxidation of jet fuels and Pennsylvania crude oil in a solid oxide fuel cell. Journal of Power Sources. 133(2). 181–187. 2 indexed citations
20.
Xu, Jing‐yu & Zaigang Zhou. (2003). Molecular dynamics simulation of liquid argon flow at platinum surfaces. Heat and Mass Transfer. 40(11). 859–869. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yupeng Wang Breakdown of academic impact, for papers by Xi Wang Breakdown of academic impact, for papers by Kai Shi Breakdown of academic impact, for papers by Conglian Yang Breakdown of academic impact, for papers by Yiyi Zhang Breakdown of academic impact, for papers by Yixian Zhou Breakdown of academic impact, for papers by Fangman Chen Breakdown of academic impact, for papers by Xiaoling Xu Breakdown of academic impact, for papers by Boyi Niu Breakdown of academic impact, for papers by Ting Wen
Rankless by CCL
2026